CELLINK, a global leader in developing and delivering life-science solutions, has joined forces with Lonza, the Swiss Chemicals and Biotechnology Company, to offer a comprehensive 3D Bioprinting solution designed to advance complete 3D cell culture workflows.
Aspect Biosystems Announces $20 Million Series-A Financing to Advance its 3D Bioprinting of Human Tissue Platform
2 Mins read
Aspect Biosystems, a biotechnology company pioneering microfluidic 3D bioprinting of human tissues, today announced a US $20 million Series-A financing round. Radical…